Drotrecogin alpha (activated) in neonatal septic shock
- PMID: 15804668
- DOI: 10.1080/00365540510031412
Drotrecogin alpha (activated) in neonatal septic shock
Abstract
A 12-d-old neonate suffering from group B streptococcal septic shock was treated with 24 microg/kg/h recombinant human activated protein C [rhAPC, drotrecogin alpha (activated)] for 96 h. The protein C activity increased from 5% to 53% after rhAPC infusion. The patient recovered within 14 d without any adverse effects.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical